Alan Gunderson | University of Iowa Clinical Research and Trials

Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

Studies

A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel Study Evaluating the Safety and Efficacy of LB-P8 in Patients with Primary Sclerosing Cholangitis (PSC)

Internal Medicine Gastroenterology Liver Disease Adult Subjects

The study is designed to assess the safety and efficacy of LB-P8 in patients with primary sclerosing cholangitis.

GigaGen GC2301 HBV

Internal Medicine Gastroenterology Liver Disease Adult Subjects

Cymabay CB8025-41837 PBC & Cirrhosis

Internal Medicine Gastroenterology Liver Disease Adult Subjects

To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.